|
Duke has been directly involved in strategic alliances since 1972 specializing in Research and Development partnerships. Duke’s main area of interest is forming alliances in the pharmaceutical, biotechnology and agricultural industries for such clients as the Donald Danforth Plant Science Center, Pfizer Inc, Colgate, the Nidus Center incubator, as well as several venture-backed companies and universities. Duke started the Washington University technology licensing office in 1982 and in 1997, he became Monsanto’s director of technology alliances. In 2002 he became Director of Global R&D Contracts and President of G.D. Searle & Co’s IP Holding Company (a Pfizer subsidiary) where he supervised a staff of patent attorneys and paralegals focused on R&D contracts and the licensing of both strategic and non-core corporate IP assets.
Duke has been a board member of Competitive Technologies Inc. (CTT -AMEX) an international technology transfer firm, He is a Past President of the Association of University Technology Managers; and was Executive Director of the first Missouri Biotechnology Association. For several years was a senior lecturer for Arthur Anderson Consulting focusing on strategic alliances. He is a board member of several startup ventures.
As a side note, Duke was part of the NAS-GUIRR team in 1985 that wrote the first model university-industry sponsored research and option agreements.
|
Contact Us